The combined neurology and neuropsychiatric categories encompass the majority of DTx products announced during 2020 as well as in nearly every year prior. DTx in neurology have many applications - from being used in pediatrics (ADHD) to geriatrics (Alzheimer's, dementia) and across use cases such as cognition, stroke rehabilitation, motor symptom and tremor control, pain management, to list a few. Join this series of 2 meetings to discuss in detail with other thought leaders the current state of DTx in neurology, what indications are best suited to such interventions, and commercial opportunities that they present.
SESSION 1: July 5th
Current DTx products in neurology: what are the most explored areas and why? What are the keys to success? What should we double down on?
SESSION 2: July 27th
Best routes to market and adoption strategies for DTx companies in neurology